These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5849 related articles for article (PubMed ID: 3784996)

  • 1. Monte Carlo dosimetry for 125I and 60Co in eye plaque therapy.
    Chiu-Tsao ST; O'Brien K; Sanna R; Tsao HS; Vialotti C; Chang YS; Rotman M; Packer S
    Med Phys; 1986; 13(5):678-82. PubMed ID: 3784996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetry for 125I seed (model 6711) in eye plaques.
    Chiu-Tsao ST; Anderson LL; O'Brien K; Stabile L; Liu JC
    Med Phys; 1993; 20(2 Pt 1):383-9. PubMed ID: 8497229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
    Thomson RM; Rogers DW
    Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold nanoparticle-based brachytherapy enhancement in choroidal melanoma using a full Monte Carlo model of the human eye.
    Asadi S; Vaez-zadeh M; Masoudi SF; Rahmani F; Knaup C; Meigooni AS
    J Appl Clin Med Phys; 2015 Sep; 16(5):344–357. PubMed ID: 26699318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 125I eye plaque dose distribution including penumbra characteristics.
    de la Zerda A; Chiu-Tsao ST; Lin J; Boulay LL; Kanna I; Kim JH; Tsao HS
    Med Phys; 1996 Mar; 23(3):407-18. PubMed ID: 8815384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
    Thomson RM; Taylor RE; Rogers DW
    Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of material heterogeneity dosimetric effects using radiochromic film for COMS eye plaques loaded with (125)I seeds (model I25.S16).
    Acar H; Chiu-Tsao ST; Ozbay I; Kemikler G; Tuncer S
    Med Phys; 2013 Jan; 40(1):011708. PubMed ID: 23298078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular brachytherapy dosimetry for 103Pd and 125I in the presence of gold nanoparticles: a Monte Carlo study.
    Asadi S; Vaez-Zadeh M; Vahidian M; Marghchouei M; Masoudi SF
    J Appl Clin Med Phys; 2016 May; 17(3):90-99. PubMed ID: 27167265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of solid phantoms with water for dosimetry of 125I brachytherapy sources.
    Meigooni AS; Meli JA; Nath R
    Med Phys; 1988; 15(5):695-701. PubMed ID: 3185404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric study of the 15 mm ROPES eye plaque.
    Granero D; Pérez-Calatayud J; Ballester F; Casal E; de Frutos JM
    Med Phys; 2004 Dec; 31(12):3330-6. PubMed ID: 15651616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development and dosimetry of a 125 iodine applicator for brachytherapy of intraocular tumors].
    Alberti W; Pothmann B; Bornfeld N; Foerster MH; Harder D; Hermann KP; Muskalla K; Tabor P; Sack H; Wessing A
    Fortschr Ophthalmol; 1990; 87(2):201-5. PubMed ID: 2358279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved treatment planning for COMS eye plaques.
    Astrahan MA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1227-42. PubMed ID: 15752905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of Monte Carlo dose calculations near 125I sources in the presence of bounded heterogeneities.
    Das RK; Keleti D; Zhu Y; Kirov AS; Meigooni AS; Williamson JF
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):843-53. PubMed ID: 9240654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
    Lesperance M; Martinov M; Thomson RM
    Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model-based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom.
    Lesperance M; Inglis-Whalen M; Thomson RM
    Med Phys; 2014 Feb; 41(2):021717. PubMed ID: 24506608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
    Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
    Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monte Carlo calculation of the dose distributions of two 106Ru eye applicators.
    Sánchez-Reyes A; Tello JI; Guix B; Salvat F
    Radiother Oncol; 1998 Nov; 49(2):191-6. PubMed ID: 10052886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of radiation dosimetry in water and in solid phantom materials for I-125 and Pd-103 brachytherapy sources: EGS4 Monte Carlo study.
    Luxton G
    Med Phys; 1994 May; 21(5):631-41. PubMed ID: 7935197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
    Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
    Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental measurements and Monte Carlo calculations for (103)Pd dosimetry of the 12 mm COMS eye plaque.
    Saidi P; Sadeghi M; Tenreiro C
    Phys Med; 2013 May; 29(3):286-94. PubMed ID: 22592132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 293.